14-day Premium Trial Subscription Try For FreeTry Free
NYSE:MSTX
Delisted

Mast Therapeutics, Inc Fund Price (Quote)

$0.130
+0 (+0%)
At Close: Jan 16, 2018

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 16th Jan 2018 MSTX stock ended at $0.130. During the day the stock fluctuated 0% from a day low at $0.130 to a day high of $0.130.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Mast Therapeutics, Inc prices

Date Open High Low Close Volume
Jan 11, 2017 $0.150 $0.160 $0.133 $0.150 21 666 519
Jan 10, 2017 $0.174 $0.179 $0.151 $0.160 24 093 757
Jan 09, 2017 $0.200 $0.230 $0.130 $0.150 98 730 938
Jan 06, 2017 $0.102 $0.102 $0.0980 $0.100 4 396 038
Jan 05, 2017 $0.105 $0.106 $0.0920 $0.100 3 105 898
Jan 04, 2017 $0.105 $0.110 $0.0960 $0.100 6 718 274
Jan 03, 2017 $0.0880 $0.0950 $0.0860 $0.100 5 142 230
Dec 30, 2016 $0.0920 $0.0950 $0.0800 $0.0900 13 382 167
Dec 29, 2016 $0.0980 $0.100 $0.0920 $0.0900 3 618 083
Dec 28, 2016 $0.100 $0.108 $0.0950 $0.100 4 026 885
Dec 27, 2016 $0.100 $0.100 $0.100 $0.100 2 703 802
Dec 23, 2016 $0.107 $0.108 $0.0980 $0.100 2 743 461
Dec 22, 2016 $0.104 $0.108 $0.102 $0.100 1 972 320
Dec 21, 2016 $0.105 $0.108 $0.100 $0.100 3 085 214
Dec 20, 2016 $0.116 $0.117 $0.102 $0.110 4 382 898
Dec 19, 2016 $0.101 $0.115 $0.0860 $0.110 8 297 082
Dec 16, 2016 $0.100 $0.105 $0.0950 $0.100 6 129 128
Dec 15, 2016 $0.110 $0.110 $0.0980 $0.100 5 720 754
Dec 14, 2016 $0.108 $0.115 $0.104 $0.110 5 055 813
Dec 13, 2016 $0.100 $0.109 $0.0950 $0.100 9 343 397
Dec 12, 2016 $0.130 $0.130 $0.105 $0.110 11 707 667
Dec 09, 2016 $0.124 $0.156 $0.107 $0.120 51 326 757
Dec 08, 2016 $0.0900 $0.123 $0.0850 $0.120 36 121 328
Dec 07, 2016 $0.0860 $0.0860 $0.0780 $0.0800 3 001 902
Dec 06, 2016 $0.0830 $0.0850 $0.0760 $0.0800 5 093 977
Click to get the best stock tips daily for free!

About Mast Therapeutics, Inc

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with significant unmet needs. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure. It also develops AIR001, a sodium nitrite solution for intermittent inhalation via nebulizer, as well as for the treatment of hear... MSTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT